Experimental sepsis in pigseffects of vasopressin on renal, hepatic, and intestinal dysfunction

Upsala Journal of Medical Sciences

Volumn 117, Issue 3, 2012, Pages 257-263

  Ji, Mu Huo ^a   Yang, Jian Jun ^a   Wu, Jing ^a   Li, Ren Qi ^a   Li, Guo Min ^b   Fan, Yun Xia ^b   Li, Wei Yan ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Blood flow; Intestine; Kidney; Liver; Sepsis; Vasopressin

Indexed keywords

CYTOKINE; VASOPRESSIN DERIVATIVE;

ANIMAL; ARTICLE; DRUG EFFECT; INTESTINE; KIDNEY; LIVER; METABOLISM; PATHOPHYSIOLOGY; SEPSIS; SWINE;

ANIMALS; CYTOKINES; INTESTINES; KIDNEY; LIVER; SEPSIS; SWINE; VASOPRESSINS;

EID: 84864865912     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2011.650796     Document Type: Article

References (25)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.
2. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E. The effects of vasopressin on systemic and splanchnic hemody-namics and metabolism in endotoxin shock. Anesth Analg. 2003;97:1756-63.
3. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877-87.
4. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 2001;27:1416-21.
5. Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, et al. Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med. 2003;168: 481-6.
6. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-5.
7. Moreau R, Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology. 2006;43: 385-94.
8. Rehberg S, Ertmer C, Vincent JL, Spiegel HU, Köhler G, Erren M, et al. Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med. 2010;38:2016-23.
9. Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol. 1996;91:1697-710.
10. Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology. 2007;106:1156-67.
11. Simon F, Giudici R, Scheuerle A, Gröger M, Asfar P, Vogt JA, et al. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care. 2009;13:R113.
12. van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999; 13:413-26.
13. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med. 1998; 158:444-51.
14. Pritts T, Hungness E, Wang Q, Robb B, Hershko D, Hasselgren PO. Mucosal and enterocyte IL-6 production during sepsis and endotoxemia\role of transcription factors and regulation by the stress response. Am J Surg. 2002;183: 372-83.
15. Russell JA, Walley KR. Vasopressin and its immune effects in septic shock. J Innate Immun. 2010;2:446-60.
16. Han X, Fink MP, Yang R, Delude RL. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock. 2004;21:261-70.
17. Westphal M, Rehberg S, Maybauer MO, Maybauer DM, Enkhbaatar P, Westphal-Varghese BB, et al. Cardiopulmo-nary effects of low-dose arginine vasopressin in ovine acute lung injury. Crit Care Med. 2011;39:357-63.
18. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10:1216-21.
19. Albert M, Losser MR, Hayon D, Faivre V, Payen D. Systemic and renal macro-and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med. 2004;32: 1891-8.
20. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487-93.
21. Guzman JA, Rosado AE, Kruse JA. Vasopressin vs norepi-nephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol. 2003;95:803-9.
22. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159-69.
23. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37:1670-7.
24. Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313-19.
25. van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest. 2003;124:2256-60.